OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2018
(3)
2023
(2)
2012
(2)
2007
(2)
2024
(1)
2022
(1)
2021
(1)
2014
(1)
2011
(1)
2010
(1)
2009
(1)
2008
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Identification of D-arabinan-degrading enzymes in mycobacteria.
Not available
S-EPMC10115798
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Not available
S-EPMC10186210
|
biostudies-literature
Cite
Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery.
Not available
S-EPMC2542439
|
biostudies-literature
Cite
Sex differences in severe pulmonary emphysema.
Not available
S-EPMC1994221
|
biostudies-literature
Cite
Integrating health status and survival data: the palliative effect of lung volume reduction surgery.
Not available
S-EPMC2724716
|
biostudies-literature
Cite
The minimal important difference of exercise tests in severe COPD.
Not available
S-EPMC5516638
|
biostudies-literature
Cite
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial.
Not available
S-EPMC3502035
|
biostudies-literature
Cite
Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema.
Not available
S-EPMC1994220
|
biostudies-literature
Cite
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
Not available
S-EPMC3233645
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets